Wolifit-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects by acting centrally to inhibit pain pathways and reduce fever. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and swelling, enhancing tissue healing. Wolifit-SP is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative inflammation, and soft tissue injuries. The synergistic action of the three components offers effective relief from pain and inflammation while improving functional mobility. It is recommended to be taken orally, preferably after meals, to minimize gastrointestinal discomfort. Caution is advised in patients with a history of gastrointestinal ulcers, bleeding disorders, hepatic or renal impairment, and hypersensitivity to any component. Use during pregnancy and lactation should be under medical supervision. Wolifit-SP should be used as directed by a healthcare professional to ensure safety and efficacy.